Optimism vs. Pessimism: The Glass Half Full Is Larger | Managed Healthcare Executive® State of the Industry Survey
Thirty-seven percent of the respondents rated themselves as optimistic about the near-term future of U.S. healthcare.
Optimism about the near future of U.S. healthcare outpaced pessimism in the Managed Healthcare Executive® annual State of the Industry survey. But it wasn’t by the largest of margins.
Thirty-seven percent of the 450 respondents to the survey rated themselves as optimistic about the near-term future of U.S. health, although the milder “somewhat optimistic” group (23%) was larger than the very optimistic group (14%). Twenty-four percent were on pessimistic, 19% classifying themselves as somewhat pessimistic and just 5% rating themselves as very pessimistic.The largest group (39%0 occupied a middle ground and rated themselves as neutral.
Phase 3 Trials of Oral Povorcitinib Show Positive Results in Hidradenitis Suppurativa
March 24th 2025A new drug application for povorcitinib is expected to be filed in late 2025 to early 2026 to treat adult patients with moderate to severe hidradenitis suppurativa, a chronic and painful inflammatory skin condition.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
FDA Approves Amvuttra for ATTR-CM in Extended Label
March 21st 2025This expanded indication for Amvuttra makes it the first and only FDA-approved treatment for transthyretin amyloidosis with cardiomyopathy (ATTR-CM) and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
